On Jan 5, 2022 Life Biosciences closed a Series C round and raised $82,000,000 from Alpha Wave Ventures, George Godula, featuring lead investors Alpha Wave […]
Seed Round – Protai
On Jan 5, 2022 Protai closed a Seed round and raised $8,000,000 from Grove Ventures, Pitango Venture Capital, featuring lead investors Grove Ventures, Pitango Venture […]
Series B – SalioGen Therapeutics
On Jan 5, 2022 SalioGen Therapeutics closed a Series B round and raised $115,000,000 from Cystic Fibrosis Foundation, D1 Capital Partners, EPIQ Capital Group, Fidelity […]
Grant – MYND Life Sciences
On Nov 30, 2021 MYND Life Sciences closed a Grant round and raised $45,600 from National Research Council of Canada Industrial Research Assistance Program, featuring […]
Post-IPO Debt – BridgeBio Pharma
On Nov 18, 2021 BridgeBio Pharma closed a Post-IPO Debt round and raised $750,000,000 from investors, featuring lead investors . About the company: BridgeBio Pharma […]
Series B – Tavotek Biotherapeutics
On Nov 18, 2021 Tavotek Biotherapeutics closed a Series B round and raised $35,000,000 from CS Capital, Fontus Capital, featuring lead investors CS Capital. About […]
Grant – Strand Therapeutics
On Nov 9, 2021 Strand Therapeutics closed a Grant round and raised $400,000 from National Cancer Institute, featuring lead investors National Cancer Institute. About the […]
Grant – DNA Script
On Nov 9, 2021 DNA Script closed a Grant round and raised $2,200,000 from National Human Genome Research Institute, featuring lead investors National Human Genome […]
Series A – Mekonos
On Nov 9, 2021 Mekonos closed a Series A round and raised $25,000,000 from Debiopharm Innovation Fund, Elementum Ventures, Fiscus Ventures, Novartis, PEAK6 Investments, Reimagined […]
Series B – Arbor Biotechnologies
On Nov 9, 2021 Arbor Biotechnologies closed a Series B round and raised $215,000,000 from Ally Bridge Group, ARCH Venture Partners, ArrowMark Partners, Deep Track […]
